Article

Forensic aspects of insulin

Post Graduate Medical School, University of Surrey, Guildford, UK. Electronic address: .
Diabetes research and clinical practice (Impact Factor: 2.54). 06/2013; 101(3). DOI: 10.1016/j.diabres.2013.05.002
Source: PubMed

ABSTRACT

Insulin or, more appropriately, hypoglycaemia gives rise to a wide variety of interactions with the law. In most cases its role is not seriously open to question occasionally however, it is. This is especially true of situations in which insulin is suspected of having been used inappropriately or maliciously. The major differences between investigation of hypoglycaemia in clinical and forensic situation are that in the latter the history is often unreliable, appropriate samples for analysis were not collected, preserved or labelled correctly and analytical results are likely to be challenged on grounds of specificity, accuracy and interpretation. Immunoassay remains the mainstay of clinical investigation of hypoglycaemia but likely to become displaced by mass-spectrometry in the forensic situation especially now that human insulin is being replaced by synthetic insulin analogues for the treatment of diabetes.

Download full-text

Full-text

Available from: Vincent Marks, Oct 09, 2014
  • Source
    • "Surreptitious or malicious exogenous insulin administration is rare but should be considered in patients with unexplained spontaneous hypoglycaemia particularly those with access to anti-diabetic drugs. It is critical to identify these cases, as hypoglycaemia resulting from insulin overdose can cause neurological injury, coma or death [3] [4] [5] [6]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Blood insulin and C-peptide are key investigations in the differential diagnosis of hypoglycaemia. Analogues of insulin have modified primary-sequences compared to native human insulin, as such may not cross react with insulin assays. This has important implications in detecting surreptitious or malicious insulin administration. The aim of this study is to assess the cross-reactivity of all insulins currently listed in the British National Formulary (BNF65, 2013) in clinical insulin assays currently used in UK clinical laboratories. Sample sets were prepared for all 15 exogenous insulin classes listed in the BNF, at concentrations of 1000pmol/L and 300pmol/L, using pooled human serum. Samples were sent blinded to 5 participating analytical laboratories to cover analysis on the 10 major clinical insulin assays used in the UK. The ability of insulin assays to detect exogenous insulin preparations was highly variable and ranged from 0% to >140% for a single exogenous insulin. Four assays were highly specific for the human insulin sequence and had no cross-reactivity with any synthetic analogue insulin. Two detected all insulin types (human sequence, animal and synthetic analogue), with the remaining having variable cross-reactivity. The cross-reactivity of the 15 exogenous insulin preparations is highly variable in the assays used in clinical laboratories around the UK. It is important that laboratories and clinicians are aware of the limitations of their local assays to avoid missing the important diagnosis of hypoglycaemia secondary to excessive exogenous insulin. Where necessary, samples should be referred to specialist centres for insulin analysis and ideally by a validated and fully-quantitative mass spectrometry-based method. Copyright © 2015. Published by Elsevier Inc.
    Full-text · Article · Jul 2015 · Clinical biochemistry
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The detection and quantification of insulin and its therapeutic analogs is important for medical, sports doping and forensic applications. Synthetic variants contain slight sequence variations to affect bioavailability. To reduce sample handling bias, a universal extraction method is required for simultaneous extraction of endogenous and variant insulins with subsequent targeted quantification by LC-MS. A mass spectrometric immunoassay (MSIA) multiplexed assay for intact insulin and its analogues that couples immunoenrichment with high resolution and accurate mass (HRAM) mass spectrometric detection across the clinical range is presented in this report. The assay is sensitive, selective, semi-automated and can potentially be applied to detect new insulin isoforms allowing their further incorporation into second or third generation assays. This article is protected by copyright. All rights reserved.
    Full-text · Article · Jun 2014 · Proteomics
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 26-year-old man, who was on probation, was found dead in his home by his mother. Insulin vials and 2 insulin pens, which the man's stepfather (an insulin-dependent diabetic) had been missing for over a week, were found next to the deceased. The circumstances suggested suicide by an injected insulin overdose. At the time of the autopsy, the corpse showed already marked signs of autolysis. Clinical chemical tests confirmed the injection of insulin, but indicated hyperglycemia at the time of death. Toxicological analyses revealed that the man had consumed amphetamine, cannabinoids, and tramadol in the recent past. Histological examination finally revealed extensive bronchopneumonia as the cause of death. The most plausible explanation for the results of the autopsy and the additional examinations was an injection of insulin as a failed attempt of self-treatment. It is conceivable that the man had discovered by a rapid test that he was a diabetic, but had decided not to go to a doctor to avoid disclosure of parole violation due to continued drug abuse. He may have misinterpreted the symptoms caused by his worsening bronchitis and the developing bronchopneumonia as symptoms of a diabetic metabolic status and may have felt compelled to treat himself with insulin.
    No preview · Article · Jan 2015